[1] Sörensen-Zender I et al. Role of fibrinogen in acute ischemic kidney injury. Am J Physiol Physiol 2013; 305: F777–F785.
[2] Kattula S, Byrnes JR, Wolberg AS. Fibrinogen and Fibrin in Hemostasis and Thrombosis. Arterioscler Thromb Vasc Biol. 2017 Mar;37(3):e13-e21
[3] Lisman T, Leuvenink HGD, Porte RJ, Ploeg RJ. Activation of hemostasis in brain dead organ donors: an observational study. J Thromb Haemost 2011; 9: 1959–1965.
[4] DiRito JR et al. Lysis of cold‐storage‐induced microvascular obstructions for ex vivo revitalization of marginal human kidneys. Am J Transplant 2021 Jan;21(1):161-173.
[5] Nieuwenhuijs-Moeke GJ et al. Preemptively and non-preemptively transplanted patients show a comparable hypercoagulable state prior to kidney transplantation compared to living kidney donors. PLoS One. 2018 Jul 16;13(7):e0200537
[6] Zorgdrager M et al. Chronic Inguinal Pain After Kidney Transplantation, a Common and Underexposed Problem. World J Surg 2017; 41: 630–638.
[7] Bösmüller et al. Detection of the BRAF V600E mutation in serous ovarian tumors: A comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR. Hum Pathol. 2013 Mar;44(3):329-35
[8] Woodside KJ et al. Enhancing kidney function with thrombolytic therapy following donation after cardiac death: a multicenter quasi-blinded prospective randomized trial. Clin Transplant 2015; 29: 1173–1180.
[9] Takeda A et al. Case study of paired cadaver renal allografts from the same donor: influence of local DIC kidney and concomitant acute rejection on early graft outcome. Clin Transpl. 1999;13 Suppl 1:13-6.
[10] Hefty TR et al. Disseminated intravascular coagulation in cadaveric organ donors incidence and effect on renal transplantation. Transplantation. 1993 Feb;55(2):442-3.
[11] Batra RK et al. Rapid Resolution of Donor-Derived Glomerular Fibrin Thrombi after Deceased Donor Kidney Transplantation. Am J Transplant. 2016 Mar;16(3):1015-20
[12] Gao G et al. Donor Characteristics, Recipient Outcomes, and Histologic Findings of Kidney Allografts With Diffuse Donor-derived Glomerular Fibrin Thrombi. Transplantation. 2019 Sep;103(9):1921-1927
[13] Hansen D, Rørvig S, Andersen CB, Sørensen SS. Fibrin thrombi in deceased donor kidneys: Prevalence and influence on graft function and graft survival in transplanted patients. APMIS. 2018 Jan;126(1):3-8
[14] Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High Survival Rates of Kidney Transplants from Spousal and Living Unrelated Donors. N Engl J Med. 1995 Aug 10;333(6):333-6
[15] Innocenti GR et al. Preemptive living donor kidney transplantation: Do the benefits extend to all recipients? Transplantation. Jan 27;83(2):144-9.
[16] Ramani AP et al. Impact of intraoperative heparin on laparoscopic donor nephrectomy. J Urol. 2005 Jul;174(1):226-8
[17] Crotty C, Tabbakh Y, Hosgood SA, Nicholson ML. Systemic Heparinisation in Laparoscopic Live Donor Nephrectomy. J Transplant 2013;2013:138926.
[18] Slegtenhorst BR, Dor FJMF, Rodriguez H, Voskuil FJ, Tullius SG. Ischemia/Reperfusion Injury and its Consequences on Immunity and Inflammation. Curr Transplant Reports. 2014 Sep 1;1(3):147-154
[19] Tietjen GT et al. Nanoparticle targeting to the endothelium during normothermic machine perfusion of human kidneys. Sci Transl Med. 2017 Nov 29;9(418):eaam6764
[20] Friedersdorff F et al. No need for systemic heparinization during laparoscopic donor nephrectomy with short warm ischemia time. World Journal of Urology. 2011 Aug;29(4):561-6
[21] Cheng EY, Leeser DB, Kapur S, Del Pizzo J. Outcomes of Laparoscopic Donor Nephrectomy Without Intraoperative Systemic Heparinization. J Urol. 2010 Jun;183(6):2282-6
[22] Madhusudhan T, Kerlin BA, Isermann B. The emerging role of coagulation proteases in kidney disease. Nature Reviews Nephrology. 2016 Feb;12(2):94-109
[23] Garcia DA, Baglin TP, Weitz JI, Samama MM. Parenteral anticoagulants - Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e24S-e43S
[24] McCall SJ, Tuttle-Newhall JE, Howell DN, Fields TA. Prognostic significance of microvascular thrombosis in donor kidney allograft biopsies. Transplantation 2003; 75: 1847–1852.
[25] Sood P, Randhawa PS, Mehta R, Hariharan S, Tevar AD. Donor kidney microthrombi and outcomes of kidney transplant: A single-center experience. Clin Transplant. 2015 May;29(5):434-8.
[26] Muczynski KA, Ekle DM, Coder DM, Anderson SK. Normal human kidney HLA-DR-expressing renal microvascular endothelial cells: Characterization, isolation, and regulation of MHC class II expression. J Am Soc Nephrol. 2003 May;14(5):1336-48.
[27] Basile DP. Rarefaction of peritubular capillaries following ischemic acute renal failure: A potential factor predisposing to progressive nephropathy. Current Opinion in Nephrology and Hypertension. 2004 Jan;13(1):1-7
[28] Nieuwenhuijs-Moeke GJ et al. Ischemia and Reperfusion Injury in Kidney Transplantation: Relevant Mechanisms in Injury and Repair. J Clin Med. 2020 Jan 17;9(1):253
[29] Martin JL, Gruszczyk A V., Beach TE, Murphy MP, Saeb-Parsy K. Mitochondrial mechanisms and therapeutics in ischaemia reperfusion injury. Pediatric Nephrology. 2019 Jul;34(7):1167-1174